Figure 2.
Diagram of patients with castration‐resistant prostate cancer who were enrolled in the low‐dose (30 000 mNAU GEN0101) or high‐dose (60 000 mNAU GEN0101) treatment groups. HVJ‐E, inactivated hemagglutinating virus of Japan envelope
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.